Skip to main content

Advertisement

Log in

Severe Neutropenia in Japanese Patients with X-Linked Agammaglobulinemia

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

X-linked agammaglobulinemia (XLA) is clinically characterized by recurrent bacterial infections during early infancy. Although it is not a phagocytic disorder, XLA is sometimes associated with neutropenia. We conducted a nation-wide survey to determine the frequency of neutropenia among Japanese XLA patients. Responses were received from 87 (86%) of 101 patients in which BTK mutations were previously identified, and of these, 16 (18%) had neutropenia. All episodes of neutropenia occurred before initiation of intravenous immunoglobulin (IVIG) replacement therapy. Two XLA patients died of multiple organ failure caused by severe neutropenia and Pseudomonas sepsis before initiation of IVIG replacement therapy. These results suggest that, in some cases, severe bacterial infections in XLA patients might be caused not only by antibody deficiencies but also by neutropenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Stiehm ER, Ochs HD, Winkelstein JA: Immunodeficiency disorders: General consideration. In Immunologic disorders in infants and children, ER Stiehm, HD Ochs, JA Winkelstein (eds). Philadelphia, WB Saunders, 2004, pp. 289–355

    Google Scholar 

  2. Conley ME, Howard V: Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr 141:566–571, 2002

    Article  PubMed  Google Scholar 

  3. Kornfeld SJ, Good RA, Litman GW: Atypical X-linked agammaglobulinemia. N Engl J Med 331: 949–951, 1994

    Article  Google Scholar 

  4. Kornfled SJ, Haire RN, Strong SJ, Tang H, Sung SS, Fu SM, Litman GW: A novel mutation (Cys145 → Stop) in Bruton’s tyrosine kinase is associated with newly diagnosed X-linked agammaglobulinemia in a 51-year-old male. Mol Med 2:619–623, 1996

    PubMed  Google Scholar 

  5. Bykowsky MJ, Haire RN, Ohta Y, Tang H, Sung SS, Veksler ES, Green JM, Fu SM, Litman GW, Sullivan KE: Discordant phenotype in siblings with X-linked agammaglobulinemia. Am J Hum Genet 58:477–483, 1996

    PubMed  Google Scholar 

  6. Hashimoto S, Miyawaki T, Futatani T, Kanegane H, Usui K, Nukiwa T, Namiuchi S, Matsushita M, Yamadori T, Suemura M, Kishimoto T, Tsukada S: Atypical X-linked agammaglobulinemia diagnosed in three adults. Intern Med 38:722–725, 1999

    PubMed  Google Scholar 

  7. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkers RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON: Deficient expression of a B cells cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279–290, 1993

    Article  PubMed  Google Scholar 

  8. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, Flinter F, Hammarstrom L, Kinnon C, Levinsky R, Bobrow M, Smith CIE, Bentley DR: The gene involved in X-linked agammaglobulinemia is a member of the src family of protein-tyrosine kinases. Nature 361:226–233, 1993

    Article  PubMed  Google Scholar 

  9. Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, Shurtleff SA: Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203:216–234, 2005

    Article  PubMed  Google Scholar 

  10. Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, Arai S, Kurimoto M, Niida Y, Matsuoka H, Sakiyama Y, Iwata T, Tsuchiya S, Tatsuzawa O, Yoshizaki K, Kishimoto T: Deficient expression of Bruton’s tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91:595–602, 1998

    PubMed  Google Scholar 

  11. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs H: Bruton’s tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinemia and carrier females. Brit J Haematol 114:141–149, 2001

    Article  Google Scholar 

  12. Amoras AL, Kanegane H, Miyawaki T, Vilela MM: Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients. J Invest Allergol Clin Immunol 13:181–188, 2003

    Google Scholar 

  13. Horwood NJ, Mahon T, McDaid JP, Campbell J, Mano H, Brennan FM, Webster D, Foxwell BM: Bruton’s tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor α production. J Exp Med 197:1603–1611, 2003

    Article  PubMed  Google Scholar 

  14. Lederman HM, Wikelstein JA: X-linked agammaglobulinemia: An analysis of 96 patients. Medicine 64:145–156, 1985

    PubMed  Google Scholar 

  15. Kozlowski C, Evans DIK: Neutropenia associated with X-linked agammaglobulinemia. J Clin Pathol 44:388–390, 1991

    PubMed  Google Scholar 

  16. Farrar JE, Rohrer J, Conley ME: Neutropenia in X-linked agammaglobulinemia. Clin Immunol Immunopathol 81:271–276, 1996

    Article  PubMed  Google Scholar 

  17. Plo Rodriguez F, Garcia Rodriguez MC, Ferreira Cerdan A, Fontan Csariego G: Neutropenia as early manifestation of X-linked agammaglobulinemia. Report on 4 patients. An Esp Pediatr 51:235–240, 1999 (in Spanish).

    Google Scholar 

  18. Tavil B, Sipahi T: Is neutropenia a clue for early diagnosis of X-linked agammaglobulinemia? Pediatr Hematol Oncol 20:657–658, 2003

    PubMed  Google Scholar 

  19. Irga N, Wierzba J, Brozek J, Ochman K, Kanegane H, Miyawaki T, Neuman-Laniec M: X-linked agammaglobulinemia (XLA) associated with agranulocytosis. Wiad Lek 56:378–30, 2003 (in Polish)

    PubMed  Google Scholar 

  20. Hashimoto S, Tsukada, Matsushita M, Miyawaki T, Niida Y, Yachie A, Kobayashi S, Iwata T, Hayakawa H, Matsuoka H, Tsuge I, Yamadori T, Kunikata T, Arai S, Yoshizaki K, Taniguchi N, Kishimoto T: Identification of Bruton’s tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: A nationwide study of Btk deficiency in Japan. Blood 88:561–573, 1996

    PubMed  Google Scholar 

  21. Kanegane H, Futatani T, Wang Y, Nomura K, Shinozaki K, Matsukura H, Kubota T, Tsukada S, Miyawaki T: Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis. J Allergy Clin Immunol 108:1012–1020, 2001

    Article  PubMed  Google Scholar 

  22. Cham B, Bonilla MA, Winkelstein J: Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol 39:107–112, 2002

    Article  PubMed  Google Scholar 

  23. Mori M, Nonoyama S, Neubauer M, Mitsuda T, Kosuge K, Yokota S: Mutation analysis and therapeutic response to granulocyte colony-stimulating factor in a case of hyperimmunoglobulin M syndrome with chronic neutropenia. J Pediatr Hematol Oncol 22:288–289, 2000

    Article  PubMed  Google Scholar 

  24. Jefferies CA, Doyle S, Brunner C, Dunne A, Brint E, Wietek C, Walch E, Wirth T, O’Neill LA: Bruton’s tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor κB activation by Toll-like receptor 4. J Biol Chem 278:26258–26264, 2003

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hirokazu Kanegane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanegane, H., Taneichi, H., Nomura, K. et al. Severe Neutropenia in Japanese Patients with X-Linked Agammaglobulinemia. J Clin Immunol 25, 491–495 (2005). https://doi.org/10.1007/s10875-005-5370-x

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10875-005-5370-x

Keywords

Navigation